Search Results - "Pérez, Alejandro Riquelme"

Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA‐MODA study by Pascual‐Figal, Domingo A., Zamorano, J. Luis, Domingo, Mar, Morillas, Herminio, Nuñez, Julio, Cobo Marcos, Marta, Riquelme‐Pérez, Alejandro, Teis, Albert, Santas, Enrique, Caro‐Martinez, Cesar, Pinilla, Jose Manuel, Rodriguez‐Palomares, Jose F., Dobarro, David, Restrepo‐Córdoba, M. Alejandra, González‐Juanatey, J. Ramón, Bayés Genís, Antoni, Figal, Domingo Pascual, Riquelme, Alejandro Pérez, Caro, Cesar, Vicente, Álvaro Hernández, Martínez, Andrés Ramón, Martínez, Mª Teresa Pérez, Noguera Velasco, Jose A., López, Iría Cebreiros, Saura, Daniel, Sandoval, Mª José Oliva, Carrillo, Josefa González, García, María Dolores Espinosa, Bayes‐Genís, Antoni, Domingo, Mar, Teis, Albert, Morillas, Herminio, Muñoz, Alfonso Valle, Jornet, Emilio Galcerá, Moya, Julia Seller, Santas, Enrique, Núñez, Julio, Espriella, Rafael, Marcos, Marta Cobo, Magalló, Belén García, Pinilla, Jose Manuel, Álvarez, Concepción Cruzado, Rubio, Clara Jiménez, Mezcua, Ainhoa Robles, Rodríguez Palomares, Jose F., Freire, Javier Limeres, Méndez, Ana B, Dobarro, David, Melendo‐Viu, María, Restrepo‐Cordoba, M. Alejandra, Goirigolzarri‐Artaza, Josebe, Ferrández‐Escarabajal, Marcos, Vega, David García, Amigo, José Seijas, Juanatey, Jose Ramón González, Comins, Martina Amiguet

“…ABSTRACT Aims Dapagliflozin improves the prognosis of patients with heart failure (HF), regardless of left ventricular ejection fraction (LVEF). However, its…”
Get full text

Colchicine in acutely decompensated heart failure: the COLICA trial by Pascual-Figal, Domingo, Núñez, Julio, Pérez-Martínez, Maria T, González-Juanatey, José Ramón, Taibo-Urquia, Mikel, Llàcer Iborra, Pau, Delgado, Juan, Villar, Sandra, Mirabet, Sonia, Aimo, Alberto, Riquelme-Pérez, Alejandro, Anguita Sánchez, Manuel, Martínez-Sellés, Manuel, Noguera-Velasco, Jose A, Ibáñez, Borja, Bayés-Genís, Antoni

“…Acute heart failure (AHF) promotes inflammatory activation, which is associated with worse outcomes. Colchicine has proven effective in other cardiovascular…”
Get full text

Colchicine in acute heart failure: Rationale and design of a randomized double‐blind placebo‐controlled trial (COLICA) by Pascual‐Figal, Domingo, Núñez Villota, Julio, Pérez‐Martínez, Maria Teresa, González‐Juanatey, José Ramón, Taibo‐Urquía, Mikel, Llàcer Iborra, Pau, González‐Martín, Javier, Villar, Sandra, Soler, Meritxel, Mirabet, Sonia, Aimo, Alberto, Riquelme‐Pérez, Alejandro, Anguita Sánchez, Manuel, Martínez‐Sellés, Manuel, Sánchez, Pedro L., Ibáñez, Borja, Bayés‐Genís, Antoni, Pascual‐Figal, Domingo, Pérez‐Martínez, Maria Teresa, Martínez, Andrés Ramón, Pérez, Alejandro Riquelme, Bravo, Iris Paula Garrido, López, Alberto Nieto, Pérez, Francisco José Pastor, Villa, Noelia Fernández, Hernández‐Vicente, Alvaro, Núñez, Julio, Villar, Sandra, Mollar, Anna, González‐Juanatey, Jose Ramón, Seijas, Jose, Ibañez, Borja, Taibo, Mikel, Talavera, Sandra Gómez, Álvarez, María López, Viyuela, Alba María Vega, Pérez, Pablo Gil, Balaguer‐Germán, Jorge, Medrado, María José Díez, Martín, Javier González, Fernandez, Laura Morán, García, Juan Carlos López‐Azor, Juan Bagudá, Javier, Cármena, M Dolores García‐Cosio, Delgado Jiménez, Juan F, LLacer, Pau, Manzano, Luis, Ruiz, Raúl, López, Genoveva, Bayes‐Genis, Antoni, Soler, Meritxell, Llibre, Cinta, Mirabet, Sonia, De Antonio, Marta, Moliner‐Abós, Carlos, Pomares, Antonia, Aimo, Alberto, Emdin, Michele, Martinez‐Selles, Manuel, Sousa, Iago, Zataraín, Eduardo, Anguita, Manuel, Sanchez, Pedro Luis

“…Aims Heart failure (HF) elicits a pro‐inflammatory state, which is associated with impaired clinical outcomes, but no anti‐inflammatory therapies have…”
Get full text

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19 by Arnaldos-Carrillo, María, Noguera-Velasco, José Antonio, Martínez-Ardil, Isabel M., Riquelme-Pérez, Alejandro, Cebreiros-López, Iria, Hernández-Vicente, Álvaro, Ros-Lucas, José Antonio, Khan, Amjad, Bayes-Genís, Antoni, Pascual-Figal, Domingo

“…Soluble suppressor of tumorigenicity-2 (sST2) is a biomarker for heart failure and pulmonary injury. We hypothesize that sST2 could help predict severity of…”
Get full text

Abstract 18216: NT-proBNP After Discharge in Patients With Decompensated Heart Failure and Preserved Left Ventricle Ejection Fraction: The NICE Study by Pascual Figal, Domingo, Gallego Navarro, Adrián, Blanco Pacheco, Javier E., Martinez-Tovar, Maria, Hernández Vicente, Álvaro, Martínez Selle, Manuel, Solé González, Eduard, Sánchez Fernández, Pedro Luis, García Pavía, Pablo, Varela Román, Alfonso, Delgado Jiménez, Juan Fco, Riquelme Perez, Alejandro, Noguera Velasco, José A, Ordóñez Llanos, Jordi, Bayés Genís, Antoni

“…Abstract only Introduction: In hospitalized patients with heart failure (HF), the transition period after discharge is associated with high risk of adverse…”
Get full text